Beş, CemalSoy, Mehmet2021-06-232021-06-2320120172-8172https://doi.org/10.1007/s00296-010-1455-9https://hdl.handle.net/20.500.12491/7184Menstrual disorders associated with the use of TNF alpha blocker have been rarely reported. Herein, we reported two cases aged 31 and 41, presenting with excessive menstrual bleeding occured after adalimumab administration which was subsequently discontinued.eninfo:eu-repo/semantics/closedAccessAdalimumabAnkylosing SpondylitisMenstrual BleedingArticle10.1007/s00296-010-1455-932721752176203522212-s2.0-84863983249Q2WOS:000305680700046Q3